Immupharma (IMM)


Latest News

ImmuPharma to reveal Lupuzor top line results by mid-April

ImmuPharma said top line results from a study of its Lupuzor drug is expected by mid-April after Simbec-Orion, the con...

Lupuzor Pivotal Phase III Study Update

RNS Number: 6822I Immupharma PLC 23 March 2018 23 March 2018 ImmuPharma PLC ("ImmuPharma" or the "Company") Lupuzor Pivotal Phase III Study Update ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company announces that it has been informed by Simbec-Orion, the contract research organisation conducting our Lu...

AIM Notice (17)

RNS Number: 7432G Immupharma PLC 05 March 2018 5 March 2018 ImmuPharma PLC ("ImmuPharma" or the "Company") AIM Rule 17 Notice ImmuPharma PLC (LSE: IMM) , specialist drug discovery and development company, announces pursuant to Rule 17 of the AIM Rules for Companies ("AIM Rules"), the following director's disclosure under Schedule T...

London Investor Evening

RNS Number: 9140E Immupharma PLC 15 February 2018 15 February 2018 ImmuPharma PLC ("ImmuPharma" or the "Company") London Investor Evening Monday 26 February 2018 @ 6pm ImmuPharma PLC (LSE: IMM) , specialist drug discovery and development company, is pleased to announce that Tim McCarthy, Chairman, will be presenting at an invest...

All News

15-12-15ImmuPharma update on Lupuzor StockMarketWire
15-12-15ImmuPharma & Simbec-Orion - Investigators MeetingRNS
08-12-15Should You Buy KAZ Minerals PLC & ImmuPharma PLC On Tuesday?Motley Fool
07-12-15ImmuPharma update on recruiting for Lupuzor trialStockMarketWire
07-12-15Update on the progress of LupuzorRNS
30-11-15Holding(s) in CompanyRNS
04-11-15Lupuzor Phase III Pivotal Trial UpdateRNS
04-11-15ImmuPharma update on Lupuzor trial StockMarketWire
04-11-15Lupuzor Phase III Pivotal Trial UpdateRNS
23-10-15ImmuPharma non-exec steps down StockMarketWire
23-10-15Directorate ChangeRNS
30-09-15Directorate ChangeRNS
30-09-15Interim ResultsRNS
29-07-15ImmuPharma chairman dies StockMarketWire
29-07-15Richard WarrRNS
27-07-15ImmuPharma clinical trials of Lupuzor 'live' StockMarketWire
25-06-15Lupuzor founder awarded 'CNRS Medal of Innovation'StockMarketWire
25-06-15Lupuzor's Founder Dr Slyviane Muller Awarded MedalRNS
29-05-15ImmuPharma resolutions passed at AGMStockMarketWire
29-05-15Result of AGMRNS
06-05-15Annual Report & AccountsRNS
06-05-15ImmuPharma appoints interim chairman StockMarketWire
06-05-15Interim Board ChangeRNS
30-04-15ImmuPharma losses narrow StockMarketWire
30-04-15Directorate ChangeRNS
30-04-15Preliminary ResultsRNS
11-02-15Immupharma completes clinical trial StockMarketWire
11-02-15CANCER UPDATE: IPP-204106RNS
27-01-15ImmuPharma gets assurance over EIS StockMarketWire
27-01-15Enterprise Investment Scheme StatusRNS
22-01-15FTSE surges as ECB unveils QE, financials riseStockMarketWire
22-01-15FTSE cautiously up as ECB's QE call nearsStockMarketWire
22-01-15Collaboration Agreement with Simbec-OrionRNS
21-10-14FTSE 100 makes strong recoveryStockMarketWire
21-10-14FTSE 100 bounces backStockMarketWire
21-10-14ImmuPharma raises £3.4m StockMarketWire
20-10-14ImmuPharma unit awarded €400,000 grant StockMarketWire
30-09-14Losses remain at ImmuPharmaStockMarketWire
27-06-14Immupharma shareholders approve AGM resolutionsStockMarketWire

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory